Eventos
ConferenciaArchivo
Determination of risk -what should be taken into consideration in Biotech and Pharma industries. / Alain Kaiser
Cambio en el contexto de la industria biotecnológica mundial: retos para el desarrollo de productos y negocios. / Einard Blanco
IP valuation practices in research institutions in Cuba: CIM/CIMAB experiences. / Einard Blanco
Exercise V.1
Exercise V.2
Maximizing the value of intangible Assets: trends in the BioPharma Industry. / Raimundo Ubieta
Practical examples of application of IP valuation methods case studies in Biotech and Pharma./ Alain Kaiser
Know Hub Chile. / Patricio A. Flores
Intellectual Property Valuation for Biotechnology and Pharmaceutical Sector. / UFRGS
Use of IP valuation software in the business Biotech and Pharma industries. / Alain Kaiser
Topic 11. Practical examples of application of IP valuation methods. / Guillem Laporta
Topic 12. Discussion on methodology applied in the case studies. / Guillem Laporta
Topic 15. Venture capital in Biotechnology. / Guillem Laporta
Topic 16. Stock market in the BioPharmaceutical Industry. / Guillem Laporta
WIPO IP Valuation Guides for Academic Institutions
Introduction to the Basic IP Valuation Issues
Topic 5. IP Valuation Practices in research institutions in Cuba. / Raimundo Ubieta